FibroGen, Inc.

FGENNASDAQHealthcare

$9.07

$-0.15(-1.63%)

Market Cap$36692186

P/E Ratio—

52W High$21.95

52W Low$4.85

Avg Volume33K

Open$9.10

Beta0.77

Overview

FibroGen, Inc. (FGEN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · FGEN · as of Mar 16, 2026

Latest filing snapshot

134

-91-40.44%vs prior year

FibroGen, Inc. (FGEN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

134

Change (1Y)

-91

Growth % (1Y)

-40.44%

Revenue / Employee

$48.1K

Net Income / Employee

$1.37M

Market Cap

$37M

FGEN Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-16	2025-12-31	134	-91	-40.44%
2025-03-17	2024-12-31	225	-261	-53.70%
2024-02-26	2023-12-31	486	-106	-17.91%
2023-02-27	2022-12-31	592	+26	+4.59%
2022-02-28	2021-12-31	566	-33	-5.51%
2021-03-01	2020-12-31	599	+68	+12.81%
2020-03-02	2019-12-31	531	+70	+15.18%
2019-02-27	2018-12-31	461	+38	+8.98%
2018-02-27	2017-12-31	423	+59	+16.21%
2017-03-01	2016-12-31	364	+11	+3.12%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Mersana Therapeutics, Inc.

102$145M #4

ALGS

Aligos Therapeutics, Inc.

70$31M #5

KZR

Kezar Life Sciences, Inc.

55$54M #6

OKUR

OnKure Therapeutics, Inc.

46$60M #7

ATNM

Actinium Pharmaceuticals, Inc.

31$33M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · FGEN peer comparison

About FGEN employees

FGEN Employees · Headcount

FibroGen, Inc. (FGEN) employee data is sourced from the annual SEC 10-K filing. As of 2025, FibroGen, Inc. had 134 full-time employees globally. Full-time employees only. Global consolidated headcount.

FibroGen, Inc. employs 134 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $48,060, reflecting the company's operational efficiency.

FibroGen, Inc.'s workforce decreased by 91 (40.44%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

FibroGen, Inc.'s revenue per employee of $48,060 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

FGEN Employees · 5 questions

As of the latest SEC 10-K filing (2025), FibroGen, Inc. had 134 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

FibroGen, Inc. employee counthow many employees does FibroGen, Inc. haveFGEN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-16